Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Tangrun Pharmaceuticals patents agents for HCV infection

Dec. 1, 2016

MicuRx Pharmaceuticals begins phase I study of MRX-4

Dec. 1, 2016

BiondVax's universal flu vaccine safe, well tolerated in phase II study

Dec. 1, 2016

A tetravalent vaccine candidate against lymphatic filariasis

Dec. 1, 2016

Walter Reed Army Institute of Research presents promising new malaria vaccine candidates

Nov. 30, 2016

Hetero Research Foundation patents antiviral agents

Nov. 29, 2016

Janssen initiates phase IIb study of simeprevir, odalasvir and AL-335 for HCV

Nov. 29, 2016

AiCuris conducting new preclinical study of AIC-649 with support from NIAID

Nov. 25, 2016

Hepatitis C candidate EDP-494 shows promise in early clinical trial

Nov. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026